Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 194.14 Million CNY | 42.33% |
| 2022 | 138.59 Million CNY | 22.03% |
| 2021 | 111.77 Million CNY | -32.43% |
| 2020 | 123.38 Million CNY | 110.21% |
| 2019 | 86.98 Million CNY | -6.57% |
| 2018 | 62.25 Million CNY | -1.76% |
| 2017 | 78.52 Million CNY | 17.11% |
| 2016 | 85.84 Million CNY | 35.03% |
| 2015 | 63.3 Million CNY | -14.0% |
| 2014 | 63.98 Million CNY | -23.67% |
| 2013 | 83.68 Million CNY | -14.44% |
| 2012 | 97.78 Million CNY | 27.43% |
| 2011 | 76.86 Million CNY | 24.97% |
| 2010 | 59.94 Million CNY | 39.19% |
| 2009 | 44.56 Million CNY | 26.47% |
| 2008 | 34.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 19.19 Million CNY | 4.9% |
| 2024 Q1 | 45.25 Million CNY | 41.78% |
| 2024 Q2 | 7.57 Million CNY | -63.5% |
| 2023 Q2 | 46.68 Million CNY | -20.09% |
| 2023 Q3 | 35.77 Million CNY | -23.37% |
| 2023 Q4 | 29.06 Million CNY | -18.75% |
| 2023 FY | - CNY | 42.33% |
| 2023 Q1 | 58.42 Million CNY | 176.28% |
| 2022 Q1 | 13.52 Million CNY | -5.58% |
| 2022 Q4 | 21.14 Million CNY | -55.27% |
| 2022 Q2 | 31.14 Million CNY | 130.21% |
| 2022 Q3 | 47.27 Million CNY | 51.81% |
| 2022 FY | - CNY | 22.03% |
| 2021 Q3 | 3 Million CNY | -94.24% |
| 2021 Q4 | 14.32 Million CNY | 376.25% |
| 2021 Q1 | 19.44 Million CNY | -71.59% |
| 2021 FY | - CNY | -32.43% |
| 2021 Q2 | 52.23 Million CNY | 168.6% |
| 2020 FY | - CNY | 110.21% |
| 2020 Q3 | 39.56 Million CNY | 61.3% |
| 2020 Q2 | 24.52 Million CNY | 74.63% |
| 2020 Q4 | 68.44 Million CNY | 73.0% |
| 2020 Q1 | 14.04 Million CNY | 33.34% |
| 2019 Q2 | 8.39 Million CNY | -13.19% |
| 2019 Q4 | 10.53 Million CNY | -55.91% |
| 2019 FY | - CNY | -6.57% |
| 2019 Q1 | 9.66 Million CNY | -69.27% |
| 2019 Q3 | 23.89 Million CNY | 184.65% |
| 2018 Q4 | 31.47 Million CNY | 218.72% |
| 2018 FY | - CNY | -1.76% |
| 2018 Q2 | 6.72 Million CNY | -59.83% |
| 2018 Q1 | 16.74 Million CNY | 20.05% |
| 2018 Q3 | 9.87 Million CNY | 46.76% |
| 2017 Q3 | 15.21 Million CNY | 3.12% |
| 2017 Q4 | 13.95 Million CNY | -8.33% |
| 2017 Q2 | 14.75 Million CNY | -43.16% |
| 2017 FY | - CNY | 17.11% |
| 2017 Q1 | 25.96 Million CNY | 70.77% |
| 2016 FY | - CNY | 35.03% |
| 2016 Q2 | 8.67 Million CNY | -59.44% |
| 2016 Q1 | 21.39 Million CNY | 176.82% |
| 2016 Q3 | 17.31 Million CNY | 99.52% |
| 2016 Q4 | 15.2 Million CNY | -12.19% |
| 2015 Q2 | 13.89 Million CNY | -28.31% |
| 2015 FY | - CNY | -14.0% |
| 2015 Q4 | 7.72 Million CNY | -15.09% |
| 2015 Q1 | 19.37 Million CNY | 90.63% |
| 2015 Q3 | 9.1 Million CNY | -34.47% |
| 2014 Q4 | 10.16 Million CNY | 1.46% |
| 2014 Q2 | 16.64 Million CNY | -24.08% |
| 2014 Q1 | 21.92 Million CNY | -23.17% |
| 2014 FY | - CNY | -23.67% |
| 2014 Q3 | 10.01 Million CNY | -39.82% |
| 2013 Q3 | 9.2 Million CNY | -47.09% |
| 2013 Q1 | 26.82 Million CNY | 9.06% |
| 2013 FY | - CNY | -14.44% |
| 2013 Q4 | 28.54 Million CNY | 210.02% |
| 2013 Q2 | 17.4 Million CNY | -35.13% |
| 2012 FY | - CNY | 27.43% |
| 2012 Q4 | 24.59 Million CNY | 16.06% |
| 2012 Q3 | 21.19 Million CNY | 23.0% |
| 2012 Q2 | 17.22 Million CNY | -34.21% |
| 2012 Q1 | 26.18 Million CNY | 5.59% |
| 2011 Q1 | 14.78 Million CNY | 0.0% |
| 2011 FY | - CNY | 24.97% |
| 2011 Q2 | 12.51 Million CNY | -15.32% |
| 2011 Q3 | 20.31 Million CNY | 62.25% |
| 2011 Q4 | 24.8 Million CNY | 22.12% |
| 2010 FY | - CNY | 39.19% |
| 2009 FY | - CNY | 26.47% |
| 2008 FY | - CNY | 0.0% |